Risperidone 2mg + Trihexyphenidyl 2mg Tablet PCD Franchise in Ahmedabad

Anti-Psychotic Medicine Supplier in Bangalore

Schizophrenia Treatment Tablet Distributor in Hyderabad

CNS Segment Pharma Franchise in Jaipur

Risperidone Combination Medicine Stockist in Mumbai
Anti-Psychotic Tablet Export & Manufacturing in Chandigarh

Home/Products /trihexyphenidyl-hydrochloride-ip-2-mg-risperidone-ip-2-mg-tablet

Risplom 2T MD Tablet

Composition : Risperidone (2mg) + Trihexyphenidyl (2mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Risplom 2T MD Tablet contains a combination of Risperidone 2mg, an atypical antipsychotic, and Trihexyphenidyl 2mg, an anticholinergic agent used to manage extrapyramidal symptoms caused by antipsychotic therapy. This combination is designed for effective management of schizophrenia, bipolar disorder, and other psychotic conditions while reducing side effects like tremors and rigidity.

Risperidone helps in controlling hallucinations, delusions, mood swings, and agitation, whereas Trihexyphenidyl prevents involuntary muscle movements and improves patient comfort.

Belonging to the CNS and psychiatry therapeutic segment, this tablet is widely prescribed by psychiatrists and neurologists, making it a high-demand medicine in hospitals, psychiatric clinics, and institutional pharmacies.

For PCD pharma franchise partners, distributors, and exporters, Risplom 2T MD Tablet offers a valuable business opportunity. It is available for third-party manufacturing, bulk institutional supply, and wholesale distribution with competitive margins and repeat demand across India.


Read More

About the Product

Risplom 2T MD Tablet contains a combination of Risperidone 2mg, an atypical antipsychotic, and Trihexyphenidyl 2mg, an anticholinergic agent used to manage extrapyramidal symptoms caused by antipsychotic therapy. This combination is designed for effective management of schizophrenia, bipolar disorder, and other psychotic conditions while reducing side effects like tremors and rigidity.

Risperidone helps in controlling hallucinations, delusions, mood swings, and agitation, whereas Trihexyphenidyl prevents involuntary muscle movements and improves patient comfort.

Belonging to the CNS and psychiatry therapeutic segment, this tablet is widely prescribed by psychiatrists and neurologists, making it a high-demand medicine in hospitals, psychiatric clinics, and institutional pharmacies.

For PCD pharma franchise partners, distributors, and exporters, Risplom 2T MD Tablet offers a valuable business opportunity. It is available for third-party manufacturing, bulk institutional supply, and wholesale distribution with competitive margins and repeat demand across India.


Common side effects include drowsiness, dizziness, dry mouth, constipation, weight gain, blurred vision, and mild hypotension. Rarely, tremors, cardiac rhythm changes, or severe allergic reactions may occur.

Risplom 2T MD Tablet is indicated for schizophrenia, bipolar disorder, irritability associated with autism spectrum disorders, and drug-induced extrapyramidal symptoms. It helps control hallucinations, agitation, mood swings, aggression, and involuntary muscle movements caused by antipsychotic therapy.

Take Risplom 2T MD Tablet exactly as prescribed. Avoid alcohol and driving until the effect of the medicine is known. Use cautiously in patients with heart disease, liver or kidney problems, glaucoma, or seizure disorders. Do not stop the medication abruptly.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation